Liquidia Corporation Common Stock vs Teradata Corporation Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $34.2 (market cap $3.04B), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.78B). The key difference: Liquidia Corporation Common Stock and Teradata Corporation Common Stock are close in size by market cap, and Teradata Corporation Common Stock is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Teradata Corporation Common Stock for 0 Days on average.
| LQDA | TDC | |
|---|---|---|
Market Cap | $3.04B | $2.78B |
Volume | 21,111,778 | 1,442,176 |
Sector | Health | Technology |
52-Week High | $91.03 | $37.88 |
52-Week Low | $22.02 | $20.71 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.94B | $2.46B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →